The antagonism of HIV Nef to SERINC5 particle infectivity restriction involves the counteraction of virion-associated pools of the restriction factor

Journal of Virology

Volumn 90, Issue 23, 2016, Pages 10915-10927

  Trautz, Birthe ^a   Pierini, Virginia ^a   Wombacher, Rebecka ^a   Stolp, Bettina ^a   Chase, Amanda J ^a   Pizzato, Massimo ^b   Fackler, Oliver T ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF TRENTO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CD4 ANTIGEN; CELL SURFACE RECEPTOR; NEF PROTEIN; PROTEIN INHIBITOR; PROTEIN KINASE LCK; PROTEINASE; SERINE INCORPORATOR 5; UNCLASSIFIED DRUG; VPU PROTEIN; MEMBRANE PROTEIN; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; SERINC5 PROTEIN, HUMAN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOPLASM; ENDOCYTOSIS; GENE MUTATION; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRACELLULAR SPACE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; RECEPTOR DOWN REGULATION; TRANS GOLGI NETWORK; VIRION; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS VIRULENCE; DOWN REGULATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MUTATION; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRULENCE; VIRUS GENE;

ANTIGENS, CD4; DOWN-REGULATION; GENES, VIRAL; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MEMBRANE PROTEINS; MUTATION; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VIRION; VIRULENCE;

EID: 85001115546     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01246-16     Document Type: Article

References (63)

1. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, Mills J. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988-991. http://dx.doi.org/10.1126/science.270.5238.988.
2. Kestler HW, III, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662. http://dx.doi.org/10.1016/0092-8674(91)90097-I.
3. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. 1995 Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 332:228-232. http: //dx.doi.org/10.1056/NEJM199501263320405.
4. Haller C, Muller B, Fritz JV, Lamas-Murua M, Stolp B, Pujol FM, Keppler OT, Fackler OT. 2014. HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins. J Virol 88:14241-14257. http://dx.doi.org/10.1128/JVI.02333-14.
5. Lambele M, Koppensteiner H, Symeonides M, Roy NH, Chan J, Schindler M, Thali M. 2015. Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells. J Virol 89:3247-3255. http://dx.doi.org/10.1128/JVI.03719-14.
6. Matheson NJ, Sumner J, Wals K, Rapiteanu R, Weekes MP, Vigan R, Weinelt J, Schindler M, Antrobus R, Costa AS, Frezza C, Clish CB, Neil SJ, Lehner PJ. 2015. Cell surface proteomic map of HIV infection reveals antagonism of amino acid metabolism by Vpu and Nef. Cell Host Microbe 18:409-423. http://dx.doi.org/10.1016/j.chom.2015.09.003.
7. Michel N, Allespach I, Venzke S, Fackler OT, Keppler OT. 2005. The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr Biol 15:714-723. http://dx.doi.org/10.1016/j.cub.2005.02.058.
8. Benson RE, Sanfridson A, Ottinger JS, Doyle C, Cullen BR. 1993. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J Exp Med 177:1561-1566. http://dx.doi.org/10.1084/jem.177.6.1561.
9. Matusali G, Potesta M, Santoni A, Cerboni C, Doria M. 2012. The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. J Virol 86:4496-4504. http://dx.doi.org/10.1128/JVI.05788-11.
10. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. 1998. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391:397-401. http://dx.doi.org/10.1038 /34929.
11. Fortin JF, Barat C, Beausejour Y, Barbeau B, Tremblay MJ. 2004. Hyper-responsiveness to stimulation of human immunodeficiency virusinfected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction. J Biol Chem 279: 39520-39531. http://dx.doi.org/10.1074/jbc.M407477200.
12. Pan X, Rudolph JM, Abraham L, Habermann A, Haller C, Krijnse-Locker J, Fackler OT. 2012. HIV-1 Nef compensates for disorganization of the immunological synapse by inducing trans-Golgi networkassociated Lck signaling. Blood 119:786-797. http://dx.doi.org/10.1182 /blood-2011-08-373209.
13. Schindler M, Munch J, Kutsch O, Li H, Santiago ML, Bibollet-Ruche F, Muller-Trutwin MC, Novembre FJ, Peeters M, Courgnaud V, Bailes E, Roques P, Sodora DL, Silvestri G, Sharp PM, Hahn BH, Kirchhoff F. 2006 Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125:1055-1067. http://dx.doi.org/10.1016/j.cell.2006.04.033.
14. Thoulouze MI, Sol-Foulon N, Blanchet F, Dautry-Varsat A, Schwartz O, Alcover A. 2006. Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity 24:547-561 http://dx.doi.org/10.1016/j.immuni.2006.02.016.
15. Schrager JA, Marsh JW. 1999. HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc Natl Acad Sci U S A 96:8167-8172. http://dx.doi.org/10.1073/pnas.96.14.8167.
16. Abraham L, Fackler OT. 2012. HIV-1 Nef: a multifaceted modulator of T cell receptor signaling. Cell Commun Signal 10:39. http://dx.doi.org/10.1186/1478-811X-10-39.
17. Sauter D, Hotter D, Van Driessche B, Sturzel CM, Kluge SF, Wildum S, Yu H, Baumann B, Wirth T, Plantier JC, Leoz M, Hahn BH, Van Lint C, Kirchhoff F. 2015. Differential regulation of NF-kappaB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins. Cell Rep 10:586-599. http://dx.doi.org/10.1016/j.celrep.2014.12.047.
18. Haller C, Rauch S, Fackler OT. 2007. HIV-1 Nef employs two distinct mechanisms to modulate Lck subcellular localization and TCR induced actin remodeling. PLoS One 2:e1212. http://dx.doi.org/10.1371/journal.pone.0001212.
19. Abraham L, Bankhead P, Pan X, Engel U, Fackler OT. 2012. HIV-1 Nef limits communication between linker of activated T cells and SLP-76 to reduce formation of SLP-76-signaling microclusters following TCR stimulation. J Immunol 189:1898-1910. http://dx.doi.org/10.4049/jimmunol.1200652.
20. Haller C, Rauch S, Michel N, Hannemann S, Lehmann MJ, Keppler OT, Fackler OT. 2006. The HIV-1 pathogenicity factor Nef interferes with maturation of stimulatory T-lymphocyte contacts by modulation of NWasp activity. J Biol Chem 281:19618-19630. http://dx.doi.org/10.1074 /jbc.M513802200.
21. Choe EY, Schoenberger ES, Groopman JE, Park IW. 2002. HIV Nef inhibits T cell migration. J Biol Chem 277:46079-46084. http://dx.doi.org /10.1074/jbc.M204698200.
22. Janardhan A, Swigut T, Hill B, Myers MP, Skowronski J. 2004. HIV-1 Nef binds the DOCK2-ELMO1 complex to activate Rac and inhibit lymphocyte chemotaxis. PLoS Biol 2:E6. http://dx.doi.org/10.1371/journal.pbio.0020006.
23. Stolp B, Imle A, Coelho FM, Hons M, Gorina R, Lyck R, Stein JV, Fackler OT. 2012. HIV-1 Nef interferes with T-lymphocyte circulation through confined environments in vivo. Proc Natl Acad Sci U S A 109: 18541-18546. http://dx.doi.org/10.1073/pnas.1204322109.
24. Stolp B, Reichman-Fried M, Abraham L, Pan X, Giese SI, Hannemann S, Goulimari P, Raz E, Grosse R, Fackler OT. 2009. HIV-1 Nef interferes with host cell motility by deregulation of cofilin. Cell Host Microbe 6:174-186 http://dx.doi.org/10.1016/j.chom.2009.06.004.
25. Chowers MY, Spina CA, Kwoh TJ, Fitch NJ, Richman DD, Guatelli JC. 1994 Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J Virol 68:2906-2914.
26. Aiken C, Trono D. 1995. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J Virol 69:5048-5056.
27. Schwartz O, Marechal V, Danos O, Heard JM. 1995. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J Virol 69:4053-4059.
28. Basmaciogullari S, Pizzato M. 2014. The activity of Nef on HIV-1 infectivity. Front Microbiol 5:232. http://dx.doi.org/10.3389/fmicb.2014.00232.
29. Laguette N, Benichou S, Basmaciogullari S. 2009. Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity. J Virol 83:1093-1104. http://dx.doi.org/10.1128/JVI.01633-08.
30. Qi M, Aiken C. 2008. Nef enhances HIV-1 infectivity via association with the virus assembly complex. Virology 373:287-297. http://dx.doi.org/10.1016/j.virol.2007.12.001.
31. Rosa A, Chande A, Ziglio S, De Sanctis V, Bertorelli R, Goh SL, McCauley SM, Nowosielska A, Antonarakis SE, Luban J, Santoni FA, Pizzato M. 2015. HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation. Nature 526:212-217. http://dx.doi.org/10.1038/nature15399.
32. Usami Y, Wu Y, Gottlinger HG. 2015. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature 526:218-223. http: //dx.doi.org/10.1038/nature15400.
33. Inuzuka M, Hayakawa M, Ingi T. 2005. Serinc, an activity-regulated protein family, incorporates serine into membrane lipid synthesis. J Biol Chem 280:35776-35783. http://dx.doi.org/10.1074/jbc.M505712200.
34. Fackler OT. 2015. Spotlight on HIV-1 Nef: SERINC3 and SERINC5 identified as restriction factors antagonized by the pathogenesis factor. Viruses 7:6730-6738. http://dx.doi.org/10.3390/v7122970.
35. Rauch S, Pulkkinen K, Saksela K, Fackler OT. 2008. Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity. J Virol 82:2918-2929. http: //dx.doi.org/10.1128/JVI.02185-07.
36. Meuwissen PJ, Stolp B, Iannucci V, Vermeire J, Naessens E, Saksela K, Geyer M, Vanham G, Arien KK, Fackler OT, Verhasselt B. 2012. Identification of a highly conserved valine-glycine-phenylalanine amino acid triplet required for HIV-1 Nef function. Retrovirology 9:34. http://dx.doi.org/10.1186/1742-4690-9-34.
37. Fackler OT, Moris A, Tibroni N, Giese SI, Glass B, Schwartz O, Krausslich HG. 2006. Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology 351:322-339. http://dx.doi.org /10.1016/j.virol.2006.03.044.
38. Pizzato M, Erlwein O, Bonsall D, Kaye S, Muir D, McClure MO. 2009 A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. J Virol Methods 156:1-7. http://dx.doi.org/10.1016/j.jviromet.2008.10.012.
39. Fritz JV, Tibroni N, Keppler OT, Fackler OT. 2012. HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin. Virology 424:33-44. http://dx.doi.org/10.1016/j.virol.2011.12.008.
40. Keppler OT, Allespach I, Schuller L, Fenard D, Greene WC, Fackler OT. 2005 Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. J Virol 79:1655-1665. http://dx.doi.org/10.1128/JVI.79.3.1655-1665.2005.
41. Rudolph JM, Eickel N, Haller C, Schindler M, Fackler OT. 2009. Inhibition of T-cell receptor-induced actin remodeling and relocalization of Lck are evolutionarily conserved activities of lentiviral Nef proteins. J Virol 83:11528-11539. http://dx.doi.org/10.1128/JVI.01423-09.
42. Muratori C, Cavallin LE, Kratzel K, Tinari A, De Milito A, Fais S, D'Aloja P, Federico M, Vullo V, Fomina A, Mesri EA, Superti F, Baur AS. 2009. Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells. Cell Host Microbe 6:218-230. http: //dx.doi.org/10.1016/j.chom.2009.06.009.
43. Stolp B, Abraham L, Rudolph JM, Fackler OT. 2010. Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling. J Virol 84:3935-3948. http://dx.doi.org/10.1128/JVI.02467-09.
44. Giese SI, Woerz I, Homann S, Tibroni N, Geyer M, Fackler OT. 2006. Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef. Virology 355:175-191. http://dx.doi.org/10.1016/j.virol.2006.07.003.
45. Geist MM, Pan X, Bender S, Bartenschlager R, Nickel W, Fackler OT. 2014 Heterologous Src homology 4 domains support membrane anchoring and biological activity of HIV-1 Nef. J Biol Chem 289:14030-14044. http://dx.doi.org/10.1074/jbc.M114.563528.
46. Manninen A, Hiipakka M, Vihinen M, Lu W, Mayer BJ, Saksela K. 1998 SH3-domain binding function of HIV-1 Nef is required for association with a PAK-related kinase. Virology 250:273-282. http://dx.doi.org /10.1006/viro.1998.9381.
47. Craig HM, Pandori MW, Guatelli JC. 1998. Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc Natl Acad Sci U S A 95:11229-11234. http://dx.doi.org/10.1073/pnas.95.19.11229.
48. Lu X, Yu H, Liu SH, Brodsky FM, Peterlin BM. 1998. Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. Immunity 8:647-656. http://dx.doi.org/10.1016/S1074-7613(00)80569-5.
49. Schorr J, Kellner R, Fackler O, Freund J, Konvalinka J, Kienzle N, Krausslich HG, Mueller-Lantzsch N, Kalbitzer HR. 1996. Specific cleavage sites of Nef proteins from human immunodeficiency virus types 1 and 2 for the viral proteases. J Virol 70:9051-9054.
50. Mangasarian A, Piguet V, Wang JK, Chen YL, Trono D. 1999. Nefinduced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J Virol 73:1964-1973.
51. Baur AS, Sass G, Laffert B, Willbold D, Cheng-Mayer C, Peterlin BM. 1997 The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 6:283-291. http: //dx.doi.org/10.1016/S1074-7613(00)80331-3.
52. Usami Y, Gottlinger H. 2013. HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity. Cell Rep 5:802-812. http://dx.doi.org/10.1016/j.celrep.2013.09.028.
53. Bresnahan PA, Yonemoto W, Ferrell S, Williams-Herman D, Geleziunas R, Greene WC. 1998. A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Curr Biol 8:1235-1238. http://dx.doi.org/10.1016/S0960-9822(07)00517-9.
54. Burtey A, Rappoport JZ, Bouchet J, Basmaciogullari S, Guatelli J, Simon SM, Benichou S, Benmerah A. 2007. Dynamic interaction of HIV-1 Nef with the clathrin-mediated endocytic pathway at the plasma membrane. Traffic 8:61-76. http://dx.doi.org/10.1111/j.1600-0854.2006.00512.x.
55. Greenberg M, DeTulleo L, Rapoport I, Skowronski J, Kirchhausen T. 1998 A dileucine motif in HIV-1 Nef is essential for sorting into clathrincoated pits and for downregulation of CD4. Curr Biol 8:1239-1242. http: //dx.doi.org/10.1016/S0960-9822(07)00518-0.
56. Ren X, Park SY, Bonifacino JS, Hurley JH. 2014. How HIV-1 Nef hijacks the AP-2 clathrin adaptor to downregulate CD4. eLife 3:e01754. http://dx.doi.org/10.7554/eLife.01754.
57. Aiken C, Konner J, Landau NR, Lenburg ME, Trono D. 1994. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853-864. http: //dx.doi.org/10.1016/0092-8674(94)90360-3.
58. Chaudhuri R, Lindwasser OW, Smith WJ, Hurley JH, Bonifacino JS. 2007 Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptor. J Virol 81:3877-3890. http://dx.doi.org/10.1128 /JVI.02725-06.
59. Pizzato M, Helander A, Popova E, Calistri A, Zamborlini A, Palu G, Gottlinger HG. 2007. Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. Proc Natl Acad Sci U S A 104:6812-6817. http: //dx.doi.org/10.1073/pnas.0607622104.
60. Usami Y, Popov S, Gottlinger HG. 2014. The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex. J Virol 88:3443-3454. http://dx.doi.org/10.1128/JVI.01933-13.
61. Lindwasser OW, Smith WJ, Chaudhuri R, Yang P, Hurley JH, Bonifacino JS. 2008. A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2. J Virol 82:1166-1174. http://dx.doi.org/10.1128/JVI.01874-07.
62. Geyer M, Yu H, Mandic R, Linnemann T, Zheng YH, Fackler OT, Peterlin BM. 2002. Subunit H of the V-ATPase binds to the medium chain of adaptor protein complex 2 and connects Nef to the endocytic machinery. J Biol Chem 277:28521-28529. http://dx.doi.org/10.1074 /jbc.M200522200.
63. Pan X, Geist MM, Rudolph JM, Nickel W, Fackler OT. 2013. HIV-1 Nef disrupts membrane-microdomain-associated anterograde transport for plasma membrane delivery of selected Src family kinases. Cell Microbiol 15:1605-1621. http://dx.doi.org/10.1111/cmi.12148.